Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Deparrtment of Pediatrics, East Jeddah General Hospital, Jeddah, Saudi Arabia.
Arab J Gastroenterol. 2020 Sep;21(3):174-178. doi: 10.1016/j.ajg.2020.07.001. Epub 2020 Jul 28.
Serological tests for coeliac disease (CD) are important in the clinical diagnosis and monitoring of response to a gluten free diet (GFD). The tests differ in their sensitivity, specificity, and diagnostic accuracy. In this study, tissue transglutaminase (IgA) (tTG-IgA) antibody was compared with the deamidated gliadin peptide (DGP), of both IgG (DGP-IgG) and IgA (DGP-IgA) types, in patients with CD.
This cross-sectional study was conducted over a period of 2 years, between 2016 and 2018, at King Abdulaziz University Hospital in children 18 years of age or younger with biopsy-proven CD. Patients' sera were tested for DGP-IgA, DGP-IgG, and tTG-IgA antibodies using enzyme-linked immunosorbent assay (ELISA). A Pearson correlation coefficient and Cohen's kappa coefficient were performed to analyse the serological tests.
The study included 26 patients with CD, with a median age of 15 years (range, 5-18 years). Seventeen patients (65.4%) were males. The median disease duration was 5 years (range, 3-14 years). Fifteen patients (57.7%) reported good adherence to a GFD. The patients' serological tests showed a mean ± SD tTG-IgA titer of 149.8 ± 75 u/ml, a mean DGP-IgG titer of 62.5 ± 36.5, and a mean DGP-IgA of 32 ± 23.3 μ/ml. We found a significant correlation between tTG-IgA and DGP-IgG (r = 0.69, P < 0.001), tTG-IgA and DGP-IgA (r = 0.67, P < 0.001), and DGP-IgG and DGP-IgA (r = 0.83, P < 0.001). Cohen's kappa coefficient (k) showed substantial agreement between tTG-IgA and DGP-IgG (k = 0.71, P < 0.001) and DGP-IgG and DGP-IgA (k = 0.69, P < 0.001), but moderate agreement between tTG-IgA and DGP-IgA (k = 0.45, P = 0.006).
We found a good correlation between tTG-IgA and DGP-IgG and tTG-IgA and DGP-IgA, and substantial agreement between tTG-IgA and DGP-IgG, but moderate agreement between tTG-IgA and DGP-IgA. These results indicate that DGP-IgG was comparable to tTG-IgA and may be useful as an alternative to tTG-IgA in the diagnosis and follow-up of patients with CD.
针对乳糜泻(CD)的血清学检测在临床诊断和监测无麸质饮食(GFD)的反应中非常重要。这些检测在灵敏度、特异性和诊断准确性方面存在差异。在这项研究中,我们比较了组织转谷氨酰胺酶(IgA)(tTG-IgA)抗体与脱酰胺麦胶肽(DGP),包括 IgG(DGP-IgG)和 IgA(DGP-IgA)两种类型,在 CD 患者中的应用。
这是一项横断面研究,在 2016 年至 2018 年期间,在阿卜杜勒阿齐兹国王大学医院对 18 岁以下经活检证实为 CD 的患者进行,检测患者血清中的 DGP-IgA、DGP-IgG 和 tTG-IgA 抗体,采用酶联免疫吸附试验(ELISA)进行检测。使用 Pearson 相关系数和 Cohen's kappa 系数来分析血清学检测结果。
本研究纳入了 26 例 CD 患者,中位年龄为 15 岁(范围,5-18 岁)。17 例(65.4%)为男性。中位疾病持续时间为 5 年(范围,3-14 年)。15 例(57.7%)患者报告良好的 GFD 依从性。患者的血清学检测结果显示 tTG-IgA 滴度的平均值±标准差为 149.8±75 u/ml,DGP-IgG 滴度的平均值±标准差为 62.5±36.5,DGP-IgA 的平均值±标准差为 32±23.3 μ/ml。我们发现 tTG-IgA 与 DGP-IgG(r=0.69,P<0.001)、tTG-IgA 与 DGP-IgA(r=0.67,P<0.001)以及 DGP-IgG 与 DGP-IgA(r=0.83,P<0.001)之间存在显著相关性。Cohen's kappa 系数(k)显示 tTG-IgA 与 DGP-IgG(k=0.71,P<0.001)和 DGP-IgG 与 DGP-IgA(k=0.69,P<0.001)之间具有高度一致性,但 tTG-IgA 与 DGP-IgA(k=0.45,P=0.006)之间具有中度一致性。
我们发现 tTG-IgA 与 DGP-IgG 和 tTG-IgA 与 DGP-IgA 之间存在良好的相关性,以及 tTG-IgA 与 DGP-IgG 之间存在高度一致性,但 tTG-IgA 与 DGP-IgA 之间存在中度一致性。这些结果表明 DGP-IgG 与 tTG-IgA 相当,可能是 CD 患者诊断和随访的替代检测方法。